A framework for longitudinal latent factor modelling of treatment response in clinical trials with applications to Psoriatic Arthritis and Rheumatoid Arthritis
NICHOLSON G. et al, (2024), Journal of Biomedical Informatics
Ethnic inequities in 6-8 week baby check coverage in England 2006-2021: a cohort study using the Clinical Practice Research Datalink.
Zhang CX. et al, (2024), The British journal of general practice : the journal of the Royal College of General Practitioners
Questionnaire survey on point-of-care ultrasound utilization during cardiac arrest among emergency physicians in Hong Kong
Lo KT. et al, (2024), Hong Kong Journal of Emergency Medicine
Ethnic inequities in routine childhood vaccinations in England 2006–2021: an observational cohort study using electronic health records
Zhang CX. et al, (2023), eClinicalMedicine, 65
Response to anti-IL17 therapy in inflammatory disease is not strongly impacted by genetic background.
Zhang C. et al, (2023), American journal of human genetics
Spatial and temporal intra-tumoral heterogeneity in advanced HGSOC: Implications for surgical and clinical outcomes.
Cunnea P. et al, (2023), Cell reports. Medicine, 4
Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis.
Mallon A-M. et al, (2021), BMC medical research methodology, 21
323 Characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer
Cunnea P. et al, (2021), Translational research biomarkers
Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer.
Rinne N. et al, (2021), Cancer drug resistance (Alhambra, Calif.), 4, 573 - 595
444 Genomic and functional characterisation of intra-tumoural heterogeneity in high grade serous ovarian cancer
Cunnea P. et al, (2020), Translational research
Abstract A10: Phenotypic and genomic characterization of intratumoral heterogeneity in high-grade serous ovarian cancer
Cunnea P. et al, (2020), Clinical Cancer Research, 26, A10 - A10